Surgical Revision

A 78-year-old man presented to clinic with long-standing left groin and thigh pain.

DALLAS — Data presented at the American Association of Hip and Knee Surgeons Annual Meeting showed proximal femoral replacement may be a reasonable salvage option in complex revision total hip arthroplasty cases.

DALLAS — In this video, Christopher N. Carender, MD, discussed results that showed surgeon volume may not be a modifiable risk factor for revision and periprosthetic joint infection after total knee arthroplasty in patients with obesity.

Arthroscopic Latarjet as a revision option for failed arthroscopic Bankart repair may yield satisfactory patient-reported outcomes with low rates of complications and recurrent instability, according to published results.

For patients with chronic periprosthetic joint infection, multistage revision total knee arthroplasty procedures were associated with high remission rates and low mortality at minimum 5-year follow-up, according to published results.

DENVER — Presented results showed supratubercle anterior closing wedge proximal tibial osteotomy did not decrease patellar height at 3 months and 6 months postoperatively for patients with failed revision ACL reconstruction.

DENVER — Younger patients who undergo revision ACL reconstruction may be at risk for limited range of motion, graft failure, poor function and pain at minimum 10-year follow-up, according to presented results.

According to published results, use of 3D-printed titanium metaphyseal cones was associated with excellent survivorship and low rates of aseptic loosening and re-revision at 5 years after revision total knee arthroplasty.

Published results showed patients who underwent revision total hip arthroplasty with a fellowship-trained surgeon had improved outcomes vs. patients who underwent surgery with a non-fellowship-trained surgeon.

Patients who underwent two-stage revision total hip arthroplasty for periprosthetic joint infection had a minimum 2-year infection-free survivorship of 73.8% and improved patient-reported outcomes at midterm to long-term follow-up.